Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,726 followers.

RT @FrontOncology: New research: Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside: Background Imm…

15 Nov 2023

Reply Repost Favourite

New research: Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside: Background Immune checkpoint inhibitor (ICI) therapy is first-line treatment for many advanced non-small cell lung cancer (aNSCLC)… https://t.co/eQqNA

15 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.